Development of an interactive model for skin and nasal antiseptic for infection prevention, allowing users to tailor settings to stakeholders’ specific circumstances at a regional or local level or within hospital departments Scientific communication of a budget impact model for prevention of surgical skin infections… Read More
Our Expertise
Data review on the burden of pertussis and other infections Burden of disease literature review on pertussis in the UK and Ireland… Read More
Willingness to pay study in meningitis… Read More
Statistical analysis of a clinical trial PRO and ClinRO data in advanced systemic mastocytosis Conference abstract and poster for a PRO analysis in advanced systemic mastocytosis PRO questionnaire development for symptoms of aggressive and indolent systemic mastocytosis Development of a PRO questionnaire in indolent systemic mastocytosis – Longitudinal data collection… Read More
Qualitative research to support development of a conceptual model and COA strategy in spinal muscular atrophy… Read More
Review of PROs in systemic sclerosis/scleroderma Brief literature review to inform endpoint strategy recommendations for interstitial lung disease in systemic sclerosis (SSc-ILD)… Read More
Defence of endpoints for Pompe’s disease… Read More
Development of a PRO for inclusion in pancreatic exocrine insufficiency studies… Read More
Defence of the use of the Orthostatic Hypotension Questionnaire (OHQ) to demonstrate treatment benefit and labelling claim in neurogenic orthostatic hypotension Validation of the OHQ in neurogenic orthostatic hypotension using clinical trial data Key opinion leader interviews on neurogenic orthostatic hypotension Evaluation of the current measurement strategy in neurogenic orthostatic… Read More
Development and validation of a PRO for masseter muscle hypertrophy In-trial validation of a PRO for masseter muscle prominence in Canada and Taiwan Development and psychometric evaluation of severity measures in masseter prominence Conceptual equivalency and psychometric evaluation of PRO and ClinRo measures of masseter muscle prominence Interim psychometric evaluation… Read More
Qualitative research to explore and support the assessment of the patient experience and impact on functioning of long-chain fatty acid oxidation disorders Qualitative interviews on long-chain fatty acid oxidation disorders… Read More
Strategic literature review to select PRO for a paediatric growth hormone deficiency trial Establishing support of content validity for the modified Injection Pen Assessment Questionnaire (IPAQ) in growth hormone deficiency Injection Pen Assessment Questionnaire (IPAQ) field study in growth hormone deficiency… Read More
Review and support for the development of a FDA dossier in patients with GNE Myopathy Development of a manuscript describing the GNE Myopathy Functional Activity Scale (GNEM-FAS) validation Development of a user manual for the GNEM-FAS validation Analysis of the GNEM-FAS validation Support for translations of the GNEM-FAS Post-hoc analyses… Read More
Qualitative research to explore and support the assessment of the patient experience and impact of functioning of movement disorders in glucose transporter type 1 deficiency syndrome, and literature review in absence seizures… Read More
Development of a COA strategy in galactosialidosis… Read More
Consultancy support for clinical trials in Fragile X syndrome Literature review to develop a conceptual model for individuals with Fragile X syndrome (aged 5-12 years old)… Read More
Literature review in dystrophic epidermolysis bullosa (DEB)… Read More
Concept elicitation interviews in Barth syndrome patients Concept selection meeting for a PRO in Barth syndrome Cognitive debriefing for Barth syndrome PROs Qualitative concept elicitation and case studies documenting the disease progression of Barth Syndrome… Read More
Manuscripts on the health economics of a pneumococcal vaccine Manuscripts on a vaccine for pneumococcal disease Payer communications on a vaccine for pneumococcal disease Responses to payer questions update on a pneumococcal disease vaccine Payer value deck update for a pneumococcal disease vaccine Payer material development on a pneumococcal disease… Read More
Economic value dossiers for influenza vaccines in a) an unprimed paediatric population and b) a primed school age population (intranasal delivery) including literature review, gap analysis and recommendations Communications package for an influenza vaccine Communication of the economics of an influenza vaccine Two manuscripts on an influenza vaccine for patients… Read More